SEC 13F Intelligence

Deep Track Capital, LP / BCAX

Deep Track Capital, LP’s Bicara Therapeutics Inc Position

Does Deep Track Capital, LP own Bicara Therapeutics Inc (BCAX)? Yes — 4.06M shares worth $81M (+1.32% of its 13F portfolio) as of Q1 2026, up from 2.61M shares the prior filed quarter.

Position Value
$81M
Q1 2026
Shares
4.06M
% of Portfolio
+1.32%
Quarters Held
7
currently held

Position History BCAX

Reported value by quarter
Q3 ’24: $20MQ3 ’24Q4 ’24: $35MQ4 ’24Q1 ’25: $26MQ1 ’25Q2 ’25: $23MQ2 ’25Q3 ’25: $38MQ3 ’25Q4 ’25: $44MQ4 ’25Q1 ’26: $81MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20264.06M$81M+1.32%
Q4 20252.61M$44M+0.78%
Q3 20252.43M$38M+1.07%
Q2 20252.43M$23M+0.72%
Q1 20252.00M$26M+0.84%
Q4 20242.00M$35M+1.30%
Q3 2024796.9K$20M+0.64%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Deep Track Capital, LP’s full portfolio or all institutional holders of BCAX.